AN2 Therapeutics, Inc. (ANTX)
Nasdaq: ANTX · Pharmaceutical Preparations · Menlo Park, CA · filing with the SEC since 2021
Who runs AN2 Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Easom Eric
Chief Executive Officer. First filing Mar 2022, latest Mar 23, 2026, 11 filings in all.
Officers reporting now
7
of 15 people with a filing in the last fifteen months
Directors reporting now
8
18 people on the record since 2022
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Eizen Joshua M | See Remarks | Oct 2022 | Nov 6, 2026 | 4 · $100,000 |
| Trenor Cameron C. III | Chief Medical Officer | Aug 2026 | Sep 16, 2026 | none |
| Williams Sarah Joanne | Principal Accounting Officer | Feb 2026 | Sep 4, 2026 | 3 · $0.00 |
| Easom Eric | Chief Executive Officer | Mar 2022 | Mar 23, 2026 | none |
| Day Lucy | Chief Financial Officer | Mar 2022 | Mar 23, 2026 | 2 · $0.00 |
| Chanda Sanjay | Chief Development Officer | Mar 2022 | Mar 23, 2026 | 2 · $0.00 |
| Prior Stephen David | Chief Strategy Officer | Nov 2024 | Jan 7, 2026 | 2 · $0.00 |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Aziz Kabeer | director | Mar 2022 | Oct 13, 2026 | none |
| Marks Gilbert Lynn | director | Mar 2022 | Oct 13, 2026 | none |
| Martin Patricia A. | director | Mar 2022 | Oct 13, 2026 | none |
| Readnour Robin Shane | director | Mar 2022 | Sep 11, 2026 | 8 · $300,000 |
| Fitzpatrick Margaret M | director | May 2022 | Sep 2, 2026 | none |
| Zakrzewski Joseph S | director | Mar 2022 | Aug 14, 2026 | none |
| Spigelman Melvin K | director | Mar 2022 | Mar 23, 2026 | none |
| Wong Stephanie | director | Mar 2022 | Mar 23, 2026 | none |
Earlier names on the record13, newest filing first
Leonard Braden Michael · 10% owner · last filing Jun 2025Kolchinsky Peter · 10% owner · last filing Aug 2024Ra Capital Healthcare Fund LP · 10% owner · last filing Aug 2024Ra Capital Management, L.P. · 10% owner · last filing Aug 2024Ra Capital Nexus Fund II, L.P. · 10% owner · last filing Aug 2024Shah Rajeev M. · 10% owner · last filing Aug 2024Eckburg Paul · officer · last filing Mar 2024Krause Kevin Michael · officer · last filing Mar 2024Adjuvant Capital Gp, L.P. · 10% owner · last filing Jan 2024Adjuvant Capital Management, LLC · 10% owner · last filing Jan 2024Adjuvant Global Health Technology Fund De, L.P. · 10% owner · last filing Jan 2024Adjuvant Global Health Technology Fund, L.P. · 10% owner · last filing Jan 2024Nazak Michael Adrian · officer · last filing Feb 2023
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.